Amicus Therapeutics, Inc.
NASDAQ:FOLD
Overview | Financials
Company Name | Amicus Therapeutics, Inc. |
Symbol | FOLD |
Currency | USD |
Price | 9.21 |
Market Cap | 2,752,003,260 |
Dividend Yield | 0% |
52-week-range | 8.79 - 14.03 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bradley L. Campbell M.B.A. |
Website | https://amicusrx.com |
An error occurred while fetching data.
About Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD